On-Demand Webinars

31. Challenges And Opportunities With Novel AAV Capsids 6/2/2026

    Explore challenges and solutions in developing novel AAV capsids, focusing on manufacturing complexity, analytical testing, and regulatory considerations for advancing gene therapy effectiveness.

32. Early Decisions, Late-Stage Consequences: How The '3S's' Determine Development Success 6/2/2026

    Gain actionable insights into how a proactive 3S approach can reduce development risks, streamline scale-up, and position your drug product for a smoother path to commercialization.

33. Quality By Design: The Future Of Automated Pharmaceutical Labeling 5/28/2026

    Learn how applying Quality by Design principles to automated labeling platforms utilizes robotics to eliminate manual errors and seamlessly adapt to future pharmaceutical packaging formats.

34. Setting A New Standard For Biotech Program Visibility 5/27/2026

    Biotech visibility improves through real-time data and centralized platforms, enabling collaboration, faster decisions, reduced risk, and better partner alignment.

35. In Vivo CAR-T And Gene Editing: Manufacturing Reality Behind The Promise 5/27/2026

    Gain practical insights into the manufacturing realities shaping in vivo CAR-T development and learn how leading teams are addressing the challenges of scaling both LNP and viral vector platforms."

36. mAb Aggregate Control On-Demand Webinar 5/22/2026

    Aggregation can undermine yield and quality in downstream mAb processing. Learn practical capture, polishing, and TFF strategies to prevent and reduce aggregates, with a focus on chromatography.

37. Straight From The Source: A Live Q&A With The Inventors Of KinetiSol™ 5/22/2026

    Experts discuss a solvent-free fusion process for amorphous solid dispersions, highlighting formulation flexibility, scale-up, process control, and early strategies to reduce risk and support commercialization.

38. How Iteration And Operational Readiness Accelerate Product-To-Patient 5/20/2026

    See how an iterative, risk‑based approach to Commissioning & Qualification shifts verification earlier, reduces late‑stage pressure, and supports smoother startups through operational readiness.

39. Cell And Gene Therapies – U.S. Payer Trends 5/20/2026

    Gain insights from U.S. payer interviews covering coverage processes, evidence requirements, and engagement strategies to accelerate market access from late-stage development through commercialization.

40. The Transformative Potential Of AI In HEOR And Market Access 5/20/2026

    HEOR teams are under pressure to move faster without sacrificing rigor. Discover how AI accelerates evidence synthesis, fills data gaps, and supports living models that meet HTA transparency standards.